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‘llmetotherapeuticAPTT Ievals
Analysisof time to achieve the APTT lower limit (figure) not previously
reported shows the sc regimen failed to achieve the lower limit by 24 to
48 hours in many patients, whereaa iv heparin did so early in moat (p =
0.004). Achieving an APIT above the lower limit early is important to clinical
outcome.
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]964-64/ increasedLipolYsi*~f~rigiYceride-Ri~h
LipoproteinsEnhancesArteryWallPermeability
andLipoproteinRetention
G. Gardner, M. Woo, 1.Goldberg, J.C. Rutledge. Universityof Ca/iforrriat
Davis,Davis,CA,USA,ColumbiaCollegeof Physiciansand.%rgeons,
NewYork,NY,USA
Triglyceride-rich lipoproteins (TGRL: chylomicrons, VLDLand IDL) are asso-
ciated with atherosclerosis; however, the mechanism promoting this effect
are largely unknown. Our goal was to examine the effect of increased lipol-
ysis on TGRL remnant flux in the artery wall. We measured fluorescently
labeled TGRL flux in rat carotid artery walls by quantitative fluorescence mi-
croscopy.The rate of accumulation (N/t) and the half life for TGRL efflux from
the artery wall (TIIZ) waa determined for each perfusion (n= 30 perfusions).
The average N/t for control TGRL perfusion was 0.16+ 0,08 mV/min. After
treatment with lipoprotein Iipase (LPL, 10 KM), the rate of TGRL accumu-
lation increased to 0.38 & 0.14 mV/min (p = 0.03). T117.for TGRL remnant
efflux from the aflery wall was 3.39 + 0.47 min during control and 4.89 +
1.24 min after addition of LpL. The reduction in TGRL remnant efflux indi-
cates increased retention in the artary wall. To further assess permeability,
hypertriglyceridemic human plasma was perfused into individual carotid ar-
teries, and flux of a fluorescently labeled water-soluble referance molacule
(dextran; 78,000 MW) was measured before and after adding LPL(10 KM) to
the perfusate. Addition of LPL significantly increased dextren accumulation
indicating increased endothelial layer permeability (0.24 + 0.1 mV/min vs.
0,9S + 0.5 mV/min). Our atudies indicate that high levels of Iipolysis pro-
mote increased endothelial layer permeability and lipoprotein accumulation.
These effects could potentate increased modification of TGRLremnants and
promote atherogenesis.
D96465 MitogenicEffectof SerotoninonVascularSmooth
Muscle Cells is Potentiated by Low Density
Lipoproteins
S.Koba, R. Pakaia; T. Katagiri, C. Benedict. TheUniversityof Texas,
Houston,TX,USA
Seclrgmund:Whsther Iowdensify lipoprotein (LOL) has amitogenic effeeton
smooth muacle cells (SMC) has been controversial. Since platalet aggrega-
tion at sites of atherosclerotic injury exposee the cells to high eoncantretion
of serotonin (5HT), a known mitogen for SMC, we axamined whethar LOL or
mildly Oxidized LDL (OX-LDL) can potentate the mitogenic efeef of 5HT on
SMC.
Methods: Primaty ao!tic rabbit SMC were grown in 10% and then 0.1%
fetal bovine serum for 72 houra. Then cells were incubated with different
concentrations of LDL or OX:LDL (mild oxidation of LDL was induced by
incubation with Cu++ which increased the thiobarbituric acid products (=
30 .pmol/mg protein) with no change in electrophoretic mobility) for 24 hrs
followed by incubation with 5HT for 24 hre. The amount of 3H-thymidine
incorporated into the ONA was then meaaurad.
o 50
5HT concentration (pM)
Resu/ts: LDL or mildly OX-LDL induced significant SMC proliferation by
themselves and this effact was potantlated by 5HT.
Corrchdorr:Thase results suggest that increased concentrations of LOL
or mildly OX-LDL may potentate the mitogenic effect of 5HT that is released
by aggregating platelets at sites of vascular damage.
M synergis’’cAugm’”~tionof =pr~ssioflof
Plasminogen Activator Inhlbltor Type I (PAI-1) in
Human Hepatoma (HepG2) Cella by Insulin and
Fatty Acids
D.J. Schneider, BE. Sobel. Univarsifyof Vermont,Burlington,Vermont,
USA
Cardiovascular mortality in patients with type II diabetes Is increased 4- to
8-fold. In addition to incraasad concentration in blcmd of inaulln, VLDL-
triglyceride (TG), and free fatty acids (FFAs) bound to albumin, PAI-I is
incraasad. To determine interactions, accumulation of PAI-1 in media mndi-
tloned by HepG2 cells was characterized in response to VLDL-Tr3, FFAa,and
insulin alone and in combination. 24-hour accumulation of PAI-I correlated
closely with the concentration of VLDL-TG (isolated from plasma of subjects
with or without type II diabetes, r = 0.91, p < 0.01). By contrast, there was
no significant correlation between VLDL-protein and accumulation of PAI-1.
Increasas in accumulation of PAI-1 in response to insulin with VLDL-TG were
synergistic as determined by the isobol and median affect methoda (e.g.
control = 30 + 2, VLDL-TG 200 mg/dl = 118 + 17, 2 nM insulin = 45 + 2,
combination = 172 + 25, p <0.01 for each). Exposure of HepG2 cells to
albumin-bound FFAs in combination with insulin reauked in aynergy aa well
(e.g. control =27 +3, 1 mM FFA38 +2, 10 nM insulin =59+ 8*, combination
=82 + 1*, ” p < 0.01). Accotdingiy, the increased concentrations of insulin,
VLOL-TGand FFAs in patients with type II diabetes may contribute toveecu-
Iopathy underlying the increased cardiovascular mortality by synergiaticelly
stimulating hepatic expression of PAI-1 consequently inhibiting a fibrinolytic
response to formation of microthrombi and occlusive thrombi.
1- platelet-~ependent~hrombin~enerationin
Patients with Hypercholesterolemia
K, Kawano, 1.Aoki, N. Aoki, K. Shimoyama, A. Maki, M. Homori,
A. Yanagisawa, Y. Kawai 1, K. Ishikawa. KyorinUniversityTokyo,Japan,
1KeioUniversityTokyo,Japan
Objectives:Coagulability was comoered before and after treatment with
pravastatin in hy~ercholesterolemicpatients by measuring theplatelet-dependent
thrombin generation to assess its value ae an index of atheroecleroeis and
to comfirm the importance of managing hyperlipidemia. Methods: Platelet-
dependent thrombin generation was measured uaing the method of Aron-
son et al. (Circulation 1992) Briefly, platelet-rich plaama (150 x IOg/L) wee
prepared and 40 mmol/L of CaC12was added to initiate clotting. S-2236
was added to each sample in a microtiter plate every 10 minutes, and the
absorbance of the relaased color product at 2 minutes was measured apac-
trophotometrically at a wavelength of 405 nm using a microtiter plate reader
to quantify the thrombin generation. Platelet-dependent thrombin generation
was measured in 51 patients (18 men, 85 women, age 59.1 + 1.7 yeara;
mean + S.E.) with hypercholesterolemia (serum total cholesterol level >
5.69 mmol/L) before and after treatment with pravastetin and in 82 nor-
mal subjects. Resufts:The thrombin generation at 30 minutea wae higher
in the pra-treated hypercholesterolamic patients as compared with that in
the control subjects (372 + 39 versus 114 + 19 mU/ml; mean + S.E., p
< 0.001). Thrombin generation in theae patients approached that of the
controls after treatment with prevastatin (180 + 27 mU/ml, pre-treatment
versus post-treatment, p < 0.001). Cone/usions:Thesedate indicate that (1)
platelet-dependent thrombin generation ia elevated in patients with hyperc-
